Devon A. Lawson

7.1k total citations · 3 hit papers
40 papers, 4.9k citations indexed

About

Devon A. Lawson is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Devon A. Lawson has authored 40 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Devon A. Lawson's work include Cancer Cells and Metastasis (16 papers), Prostate Cancer Treatment and Research (13 papers) and Single-cell and spatial transcriptomics (8 papers). Devon A. Lawson is often cited by papers focused on Cancer Cells and Metastasis (16 papers), Prostate Cancer Treatment and Research (13 papers) and Single-cell and spatial transcriptomics (8 papers). Devon A. Lawson collaborates with scholars based in United States, Poland and Taiwan. Devon A. Lawson's co-authors include Owen N. Witte, Xin Li, Zena Werb, Kai Kessenbrock, Donghui Cheng, Rita U. Lukacs, Andrew S. Goldstein, Ryan T. Davis, Owen N. Witte and Nicholas Pervolarakis and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Devon A. Lawson

40 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells

2015 690 citations Devon A. Lawson, Kai Kessenbrock et al. profile →
Tumour heterogeneity and metastasis at single-cell resolution

2018 413 citations Devon A. Lawson, Kai Kessenbrock et al. Nature Cell Biology profile →
Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade

2024 44 citations Shannon M. Pfeiffer, Jacob Insua‐Rodríguez et al. Nature Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Devon A. Lawson United States	31	2.8k	2.3k	1.5k	1.3k	473	40	4.9k
Katharine Romans United States	18	2.6k 1.0×	2.0k 0.9×	1.2k 0.8×	2.5k 1.9×	548 1.2×	25	5.5k
Maria Cristina Manara Italy	45	2.9k 1.1×	1.6k 0.7×	2.4k 1.5×	1.3k 1.0×	448 0.9×	117	5.5k
Joana Paredes Portugal	40	2.6k 1.0×	1.9k 0.8×	577 0.4×	1.2k 0.9×	344 0.7×	95	4.5k
Yanan Kuang United States	25	2.4k 0.9×	2.1k 0.9×	2.3k 1.5×	2.1k 1.6×	282 0.6×	39	4.8k
Thomas G. P. Grünewald Germany	37	2.7k 1.0×	1.0k 0.5×	1.0k 0.7×	1.1k 0.9×	456 1.0×	103	4.4k
M. OʼReilly United States	14	3.7k 1.3×	1.9k 0.8×	741 0.5×	2.2k 1.7×	719 1.5×	30	6.0k
Jochen B. Geigl Austria	31	2.2k 0.8×	2.2k 1.0×	1.2k 0.8×	3.0k 2.3×	247 0.5×	52	5.1k
Deric L. Wheeler United States	37	2.5k 0.9×	2.5k 1.1×	1.3k 0.8×	751 0.6×	620 1.3×	89	4.8k
Alicia Viloria‐Petit Canada	23	2.4k 0.9×	1.4k 0.6×	704 0.5×	1.3k 1.0×	297 0.6×	48	3.8k
Margaret Leversha United States	24	1.9k 0.7×	1.7k 0.8×	1.3k 0.9×	1.3k 1.0×	662 1.4×	37	4.5k

Countries citing papers authored by Devon A. Lawson

Since Specialization

Citations

This map shows the geographic impact of Devon A. Lawson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devon A. Lawson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devon A. Lawson more than expected).

Fields of papers citing papers by Devon A. Lawson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devon A. Lawson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devon A. Lawson. The network helps show where Devon A. Lawson may publish in the future.

Co-authorship network of co-authors of Devon A. Lawson

This figure shows the co-authorship network connecting the top 25 collaborators of Devon A. Lawson. A scholar is included among the top collaborators of Devon A. Lawson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devon A. Lawson. Devon A. Lawson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pfeiffer, Shannon M., Jacob Insua‐Rodríguez, Hamad Alshetaiwi, et al.. (2024). Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade. Nature Immunology. 25(7). 1257–1269. 44 indexed citations breakdown →

Mallya, Sharmila, et al.. (2023). Multiomic and spatial immunophenotyping reveals a prominent Runx3+ resident T cell population in the healthy human breast. The Journal of Immunology. 210(Supplement_1). 63.12–63.12. 1 indexed citations

Davis, Ryan T., Kerrigan Blake, Dennis Ma, et al.. (2020). Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing. Nature Cell Biology. 22(3). 310–320. 200 indexed citations

Nguyen, Quy, Nicholas Pervolarakis, Kerrigan Blake, et al.. (2018). Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity. Nature Communications. 9(1). 2028–2028. 230 indexed citations

Lawson, Devon A., Kai Kessenbrock, Ryan T. Davis, Nicholas Pervolarakis, & Zena Werb. (2018). Tumour heterogeneity and metastasis at single-cell resolution. Nature Cell Biology. 20(12). 1349–1360. 413 indexed citations breakdown →

Takai, Ken, Allison P. Drain, Devon A. Lawson, et al.. (2018). Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancers. Genes & Development. 32(3-4). 244–257. 56 indexed citations

Parker, Ian, Katrina Evans, Kyle L. Ellefsen, Devon A. Lawson, & Ian F. Smith. (2017). Lattice light sheet imaging of membrane nanotubes between human breast cancer cells in culture and in brain metastases. Scientific Reports. 7(1). 11029–11029. 14 indexed citations

Liu, Linan, Shirley X. Zhang, Wenbin Liao, et al.. (2017). Mechanoresponsive stem cells to target cancer metastases through biophysical cues. Science Translational Medicine. 9(400). 78 indexed citations

Cooke, Daniel L., David McCoy, Van V. Halbach, et al.. (2017). Endovascular Biopsy: In Vivo Cerebral Aneurysm Endothelial Cell Sampling and Gene Expression Analysis. Translational Stroke Research. 9(1). 20–33. 31 indexed citations

10.

Lawson, Devon A., Zena Werb, Yang Zong, & Andrew S. Goldstein. (2015). The Cleared Mammary Fat Pad Transplantation Assay for Mammary Epithelial Organogenesis. Cold Spring Harbor Protocols. 2015(12). pdb.prot078071–pdb.prot078071. 13 indexed citations

11.

Kessenbrock, Kai, Gerrit J.P. Dijkgraaf, Devon A. Lawson, et al.. (2013). A Role for Matrix Metalloproteinases in Regulating Mammary Stem Cell Function via the Wnt Signaling Pathway. Cell stem cell. 13(3). 300–313. 103 indexed citations

12.

Plaks, Vicki, Audrey Brenot, Devon A. Lawson, et al.. (2013). Lgr5-Expressing Cells Are Sufficient and Necessary for Postnatal Mammary Gland Organogenesis. Cell Reports. 3(1). 70–78. 168 indexed citations

13.

Littlepage, Laurie E., Adam S. Adler, Hosein Kouros‐Mehr, et al.. (2012). The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression. Cancer Discovery. 2(7). 638–651. 54 indexed citations

14.

Jiao, Jing, Antreas Hindoyan, Shunyou Wang, et al.. (2012). Identification of CD166 as a Surface Marker for Enriching Prostate Stem/Progenitor and Cancer Initiating Cells. PLoS ONE. 7(8). e42564–e42564. 93 indexed citations

15.

Zong, Yang, Xin Li, Andrew S. Goldstein, et al.. (2009). ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells. Proceedings of the National Academy of Sciences. 106(30). 12465–12470. 157 indexed citations

16.

Mulholland, David J., et al.. (2009). Lin−Sca-1+CD49fhigh Stem/Progenitors Are Tumor-Initiating Cells in the Pten -Null Prostate Cancer Model. Cancer Research. 69(22). 8555–8562. 143 indexed citations

17.

Lukacs, Rita U., Devon A. Lawson, Yiwei Zong, et al.. (2008). Epithelial Stem Cells of the Prostate and Their Role in Cancer Progression. Cold Spring Harbor Symposia on Quantitative Biology. 73(0). 491–502. 14 indexed citations

18.

Lawson, Devon A. & Owen N. Witte. (2007). Stem cells in prostate cancer initiation and progression. Journal of Clinical Investigation. 117(8). 2044–2050. 137 indexed citations

19.

Li, Xin, Devon A. Lawson, & Owen N. Witte. (2005). The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proceedings of the National Academy of Sciences. 102(19). 6942–6947. 339 indexed citations

20.

Lawson, Devon A., Xin Li, Rita U. Lukacs, et al.. (2005). Prostate Stem Cells and Prostate Cancer. Cold Spring Harbor Symposia on Quantitative Biology. 70(0). 187–196. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact